Heart drug pipeline
Drugmakers eye Lp(a) as next big test in heart medicine
Novartis, Amgen and Eli Lilly are in late-stage trials to see whether sharply lowering a genetic cholesterol risk can prevent heart attacks
Heart disease news
Read verified news on BetaVoices covering Heart disease, with reporting, context, and related developments.
#Heart disease
Clear filters